chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient was vaccinated with expired PNEUMOVAX 23 (lot # 669776/0614AA, exp date 27-SEP-2012) on 12-OCT-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse event reported. It was unknown if the patient had sought medical attention. Additional information has been requested.
Expired while sleeping approximately 12 - 18 hours after Flu vaccine administered. Coroner's case. Additonal term added from autopsy report: Atheroscleric CAD/sr
This initial spontaneous report was received on 19-JAN-2017 from a female licensed practical nurse (LPN) who reported that multiple unspecified patients "over 14 years of age" received either dose 2 or dose 3 of GARDASIL 9 one to two years after receiving the previous dose of GARDASIL 9 (unspecified dates) which is outside of the recommendations in the GARDASIL 9 prescribing information. The vaccination(s) route, site, Lot #, expiration date and indication were not reported. No adverse effect reported. No further information was reported. Additional information received on 20-JAN-2017, from the same female licensed practical nurse (LPN) reported the date(s) of the administration of GARDASIL 9 for this male (age unknown) were reported to be 1) 11-AUG-2016 and 2) 24-OCT-2016. [These dates were as reported. It was also written next to the 24-OCT-2016 date (due 24-FEB-2017.) No further information was reported. Additional information has been requested. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1701USA009269: US-009507513-1701USA009269: US-009507513-1701USA009269.
A pharmacist administered the wrong vaccine. Instead of giving the patient the regular Pfizer vaccine, she got the pediatric Pfizer.
Itchy; Chills; Rash; protruding chest pain; sore arm one week later after moderna vaccine; Flushing; HOARSENESS; Left breast is hurting and has noticeable lymph nodes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (protruding chest pain), LIMB DISCOMFORT (sore arm one week later after moderna vaccine), PRURITUS (Itchy), FLUSHING (Flushing) and DYSPHONIA (HOARSENESS) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ALPRAZOLAM, TRIAMTERENE and RABEPRAZOLE SODIUM (ACIPHEX) for an unknown indication.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced CHEST PAIN (protruding chest pain), LIMB DISCOMFORT (sore arm one week later after moderna vaccine), FLUSHING (Flushing), DYSPHONIA (HOARSENESS) and LYMPH NODE PAIN (Left breast is hurting and has noticeable lymph nodes). On 24-Apr-2021, the patient experienced PRURITUS (Itchy), CHILLS (Chills) and RASH (Rash). The patient was treated with HYDROCORTISONE ongoing from 19-May-2021 for Adverse event, at an unspecified dose and frequency; VALACICLOVIR HYDROCHLORIDE (VALTREX) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency; MOMETASONE ongoing from 19-May-2021 for Adverse event, at an unspecified dose and frequency and CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, CHEST PAIN (protruding chest pain), LIMB DISCOMFORT (sore arm one week later after moderna vaccine), FLUSHING (Flushing), DYSPHONIA (HOARSENESS) and LYMPH NODE PAIN (Left breast is hurting and has noticeable lymph nodes) outcome was unknown and PRURITUS (Itchy), CHILLS (Chills) and RASH (Rash) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication include Benadryl and Clotran. Other Medications Include Vdtex.   This case was linked to MOD-2021-075107, MOD-2021-075107 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-May-2021: Followup received and treatment medications were added. On 01-Jul-2021: Follow up received and patient demograpics were added. Concomitant medications were added. Events were added.
C/O SHAKY, NERVOUS/ANXIOUS, HAS HX DM, HTN, ANXIETY. BS=95, SYMPTOMS RESOLVED, REFUSED TRANSPORT.
5 minutes after the vaccine, I did have some tongue swelling, back 1/3 of tongue, however did not increase in amount, stayed the same until early evening. I did pre-medicate with Benadryl and Ibuprofen. After returning home added Benadryl and then Benadryl at bedtime. I also had slight leg cramps for approximately 2 hours post injection that lasted about an hour. No further tongue swelling at bedtime, back to normal.
The whole family took at-home test of COVID-19 before congregating with family for Christmas. A couple of days after Christmas, he said he was feeling achy and congested. He went and got tested for COVID-19 at the local clinic. On 01/01/2022, he felt terrible and couldn't move so I took him to the emergency room. They gave him the antiviral antibody Sotrovimab. He was there for hours and was discharged. He came back home, and he said he felt better than ever. He regained his appetite and was able to be more mobile on his own. A few days later on 01/04/2022, he said he felt weak. He was really dehydrated, so we had to go back to the hospital again for another round. Since then, he's been fine and only has a lingering cough. He hasn't had any health issues since then.
Shot given at 9AM. By 2:30PM patient was nauseated, weak and hot all over. Right upper arm was swollen red and painful. She felt she couldn't move her arm. Stayed in bed Saturday. Sunday she felt a little better. Today (Monday) there is minimal swelling in her right arm. Her arms is tender with patches of red on her upper arm and it is stiff.
Soreness and swelling at injection site (right arm); Soreness and swelling at injection site (right arm); Fatigue; Nausea; Headache; This is a spontaneous report from a contactable consumer (patient). This 26-year-old non-pregnant female consumer received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EN5318) via unspecified route of administration in the right arm on 27Jan2021 at 11:00 (at the age of 26-years-old) as a single dose for COVID-19 immunization. Medical history was not reported. The patient did not have COVID-19 prior to vaccination, and did not receive any other vaccines in the 4 weeks prior to vaccination. Concomitant medications included paracetamol (TYLENOL) from an unknown date for an unknown indication; ibuprofen (ADVIL) from an unknown date for an unknown indication; and ethinylestradiol, etonogestrel (NUVARING) from an unknown date for an unknown indication. On 27Jan2021 at 21:00 the patient experienced soreness and swelling at injection site (right arm), fatigue, nausea, and headache, all lasting 24 hours after inoculation. No treatment was received for the events. The clinical outcomes of soreness and swelling at injection site (right arm), fatigue, nausea, headache, were recovered on 28Jan2021 at 21:00. It was also reported the patient did not test for COVID-19 post vaccination.
Patient believes the injection went under the skin not muscularly; Formed a knot; Feels hot, got heat in it; Got blister on skin; Increasingly worse; itching of skin; Injection site  kind of burn; Spread bigger and red; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient believes the injection went under the skin not muscularly), VACCINATION SITE MASS (Formed a knot), VACCINATION SITE WARMTH (Feels hot, got heat in it), BLISTER (Got blister on skin) and CONDITION AGGRAVATED (Increasingly worse) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history were reported.  Concomitant products included DIAZEPAM, DULOXETINE, TRAZODONE and METFORMIN for an unknown indication.    On 06-Mar-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient believes the injection went under the skin not muscularly), VACCINATION SITE MASS (Formed a knot), VACCINATION SITE WARMTH (Feels hot, got heat in it), BLISTER (Got blister on skin), CONDITION AGGRAVATED (Increasingly worse), PRURITUS (itching of skin), VACCINATION SITE PAIN (Injection site  kind of burn) and VACCINATION SITE ERYTHEMA (Spread bigger and red). On 06-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Patient believes the injection went under the skin not muscularly) had resolved. At the time of the report, VACCINATION SITE MASS (Formed a knot), VACCINATION SITE WARMTH (Feels hot, got heat in it), BLISTER (Got blister on skin), CONDITION AGGRAVATED (Increasingly worse), PRURITUS (itching of skin), VACCINATION SITE PAIN (Injection site  kind of burn) and VACCINATION SITE ERYTHEMA (Spread bigger and red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication include vitamins. No treatment medication details was reported.       Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow-up information received on 17-JUN-2021. No new information was updated
Discharge Date: Jul 22, 2022 Discharge Provider: MD Primary Care Provider : Clinic Physician, MD None   Admission Date: 7/20/2022  PRESENTING PROBLEM: Pneumonia due to COVID-19 virus   HOSPITAL COURSE: 85 yo female with history of oxygen-dependent chronic obstructive pulmonary disease on baseline 2 L of oxygen, history of left upper lobe squamous cell carcinoma, was brought to the emergency department from her long-term care facility secondary to dyspnea, hypoxia and positive for COVID.  Chest x-ray revealed chronic obstructive pulmonary disease changes with mild bibasilar airspace disease.  Patient was continued on her chronic obstructive pulmonary disease inhalers and started on Decadron 6 mg orally daily.  Patient was monitored in the hospital for about 48 hours and patient did not have any worsening of her symptoms and she continued to only required 2 L of oxygen which is her baseline.  Patient was discharged back to her living facility and she is to continue with 7 more days of Decadron to finish a total 10 day course.
Ecchymosis , redness, warmth at injection site  Redness and warmth persisting
macular/papular rash on upper chest and back which started 4 days after reveiving vaccine - afebrile
Patient stated she felt numbness over her covid-19 vaccination injection site moments after receiving the injection followed by radiation to though her shoulder, lower arm and chest. She felt a lump in her throat with no visible swelling. She then stated she felt chest pain. EMS was called at approximately 1734 hours and arrived at 1755 hours. Patient agreed to leave via EMS. Vitals stabilized while on scene into normal ranges after initial pulse of 100. BP 122/82, HR 100, SpO2 100% -- > BP 118/84 HR 97, SpO2 99% -- > BP 110/82 HR 84 SpO2 98%.
Pt reported a swollen arm that subsided 4 days after ZOSTAVAX vaccine was administered. Pt saw PCP were said it may be an allergy. Vaccine administered on May 18, 2009 + Pt reported 08 am ~  may 22/09.
Patient fainted after vaccination, while waiting in the seating area during the 15 min observation period
11/11/2005 7:00 arm red, inflamed, warm to touch approx size 1" dm. 11/12/05 joint achiness, no fever, no H/A, mild nausea, fatigue, redness, swelling 3" dm to arm. 11/13/2005 same symptoms but intensified, BP increased, itching to left arm receiving treatment.
Erythema and induration at injection site. Less than 24 hours after receiving vaccine. Antihistamine given, advised to apply ice twice a day.
Had headache that lasted 4 days, a fever for a little over 2 days that went up to 102.5 Fahrenheit (finally took Tylenol at that point because I didn't want it to go any higher), tired/fatigue, fever, chills, and a wooziness when I stood up.
Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Chills-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: Patient recieved covid booster moderna on monday 2/7/22. After a couple of days patient reports of not being able to lift arm and complains of tenderness and warm to the touch.  Patient went to a HCF and was advised to come back to the pharmacy and speak to someone to have visit covered by the pharmacy.
24hr p/vax onset of redness small amount swelling & warm to touch on 4APR in AM more redness & swelling & hot to touch area approx 3 1/2" x 3 1/2 irregular in shape;
vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 18Jul2022; No adverse event; Administered the vaccine to patient after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 18Jul2022) and NO ADVERSE EVENT (No adverse event) in a 47-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 18-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 18Jul2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 18Jul2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 18Jul2022).    No concomitant medications were provided by the reporter.  The number of doses/vials administered were 35 vials. Date the vial was initially stored in the refrigerator was 04-Jun-2022. The vaccines were administered from the 04-Jun-2022 until the 26-Jul-2022. The vial did not undergo any temperature excursions.  No treatment medications were provided by the reporter
This spontaneous report as received from certified medical assistant (C.M.A) refers to a 12 year old patient of unknown gender. On an unknown date in 2014 (reported as "within las weak"), the patient was vaccinated with a dose of (Oka/Merck) VARIVAX Lot # J013730, exp. date 30-OCT-2015, (dose, route and site of administration were not reported) that was improperly stored. No concomitant medications were reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Metallic taste in the mouth for 45-minutes; Neck muscles felt tight; Headache; Chills; Joint aching; Very cold; Fatigue; Sleeping; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the left arm on an unknown date in Apr2021(at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, sleeve gastrectomy, obesity, penicillin allergy, latex allergy, allergy to nuts and peanut allergy. Concomitant medications included calcium (MANUFACTURER UNKNOWN), cyanocobalamin-tannin complex (B12), vitamin d nos (VITAMIN D), zinc (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Apr2021, the patient experienced metallic taste in the mouth for 45-minutes, neck muscles felt tight, headache, chills, joint aching, very cold, fatigue, slept on and off for 24 hours. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events metallic taste in the mouth for 45-minutes, neck muscles felt tight, headache, chills, joint aching, very cold, fatigue, slept on and off for 24 hours were resolved on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Metallic tin foil taste with everything I eat, daily migraines, heart fluctuations, constant debilitating soreness in arm I was injected in. These side effects started after first injection and stayed with me everyday since then, at this point I am seriously concerned and my doctor said to report it to this site.
3" x 3" hive on right subcat. area when immunization was given. Seen by clinic 48 hours later.
Joint pain, swelling in right knee, shoulder pain, neck pain, muscles in back of legs had pain and arms as well, found it hard to move without assistance.
patient experienced fatigue, fever, malaise and reported swelling in her right arm at the injection site
Patient's mother noted scattered vesicles on patient's head that developed approximately 2 weeks after vaccination. Vesicles localized only to patient's scalp and scabbed over after about 2-3 days, patient's mother reports he had 1 day of "low grade fever" but all symptoms resolved by 6/2. Patient was not evaluated in the office due to transportation concerns.
pt recv vax 3SEP97 & c/o not feeling well on 4SEP97, t99;vaccine related URI sent off duty; 5SEP t100.4-off duty;8SEP c/o h/a & t101;
got shot, still got it in face/suspected vaccination failure; got shot, still got it in face; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 24-SEP-2022 Reporter's Comment: This case was reported via interactive digital media. The reporter stated that friend's mother (patient) got the shot for shingles and still got it on her face, but it was not be week. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available. This case was one of 4 cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR134884:Same reporter US-GLAXOSMITHKLINE-US2022AMR134920:Same reporter US-GSK-US2022AMR134931:Same reporter
Redness to injection site of left thigh, noticed 9/18/2019.  Mild warmth to the area, tender to the area as well reported by family. Provider notes from 9/19/2019: positive erythematous lesion approximately 9 cm in diameter upper lateral region of left thigh, two small injection sites noted central of lesion approximately 1 inch apart. No induration noted, very mild warm to touch, no tenderness noted with palpation.
Global severe body ache with fever. 24 hours later: onset progressively worse joint pain and swelling in wrist, hands, fingers and knees with associated restriction of movement.
adverse reactions; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (adverse reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced ADVERSE DRUG REACTION (adverse reactions). At the time of the report, ADVERSE DRUG REACTION (adverse reactions) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested
This spontaneous report was received from a registered nurse referring to an unspecified number of patients. Pertinent medical history, allergies and drug reactions were not reported. On 27-JUL-2016, the patients were vaccinated with an unspecified number of improperly stored doses of RECOMBIVAX HB lots # K021444 and M008551, expiry dates 17-SEP-2017, 27-NOV-2017 and 02-JUN-2018 respectively. The doses and routes of administration were not reported. At the same date no adverse events were reported. Additional information has been requested.
Patient did not have an Adverse recaction. Patient was accidentally given two injections of Yellow Fever.
Racing heart, heart palpitations, dizziness, nausea, rash on arm, swollen lymph nodes, difficulty speaking, symptoms beginning approximately 6 hours after dose and lasting up to 6 weeks. Arm and hand was numb and tingly right after getting vaccination
Rash is not listed; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingles vaccine.     Additional Information: GSK receipt date: 19-OCT-2022 Reporters comment: This case was reported by a consumer via interactive digital media. The patient received shingle vaccine and experienced rash and reported it was not listed.
She reports that later the evening on the day she received the seasonal influenza vaccine, she had the following symptoms: headache, joint pain, muscle aches chills and fever (feeling hot and cold) "like I had the flu". Although she self medicated with Tylenol cold and flu tablets and Theraflu, the symptoms lasted approximately 96 hours requiring her to miss work. She denies any local pain, shortness of breath, skin eruptions, nausea or vomiting, dizziness or respiratory symptoms. She also denies reactions like this with other vaccines and denies egg allergy.